Recombinant Human SLAMF1 (C-6His)

Description

EnkiLife provides the Recombinant Human SLAMF1 (C-6His) protein,aslo know as Signaling Lymphocytic Activation Molecule,CDw150,IPO-3,CD150,SLAMF1,SLAM, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Signaling Lymphocytic Activation Molecule is produced by our Mammalian expression system and the target gene encoding Ala21-Pro237 is expressed with a 6His tag at the C-terminus.Accession:Q13291. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:25.33 KDa. Background:SLAM-induced signal-transduction events in T-lymphocytes are different from those in B-cells. Two modes of SLAM signaling are likely to exist: one in which the inhibitor SH2D1A acts as a negative regulator and another in which protein-tyrosine phosphatase 2C (PTPN11)-dependent signal transduction operates.